Contracts Finder · Award

NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1

A public procurement published by NHS England via Contracts Finder.

Contracts FinderAward
£11m
Award value
£5.5m
Tender value
3
Suppliers
6
Awards
2
Notices
Award
Stage

Overview

NHS England has created a Framework Agreement with 5 providers who are able to provide between them up to 10,500 behavioural interventions annually across the 42 Integrated Care Systems (ICS) in England. The Framework providers are; Counterweight, Xyla, Reed Wellbeing, Oviva and Momenta Newcastle. The Framework Agreement will include an option for it to be extended for a further 12 months in addition to the initial 2 year term upon review. During the term of the Framework and any extension period, NHS England reserves the right, should funding become available, to increase the number of behavioural interventions. Wave 1 was for 10 ICSs with the following Framework suppliers being suc…

Key details

Source
Contracts Finder
Lifecycle stage
Award
Status
complete
CPV classification
85100000 — Health services
Currency
GBP
Total award value
£10,962,786
Tender value
£5,481,393
First published
20 Feb 2024
Last updated
20 Feb 2024
View the original notice

Awards

6 awards recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
Pulse Healthcare Limited031561036 Aug 2023active£5.5m
Oviva UK Limited096677846 Aug 2023active£5.5m
Momenta Newcastle Ltd123710576 Aug 2023active£5.5m
Pulse Healthcare Limited031561036 Aug 2023active£5.5m
Oviva UK Limited096677846 Aug 2023active£5.5m
Momenta Newcastle Ltd123710576 Aug 2023active£5.5m

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Award noticeNHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1
  2. Award noticeNHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1

All suppliers

Frameworks & programmes

More from NHS England

FAQs about this procurement

Who is the buyer for "NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1"?

NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1 is a UK public-sector procurement published by NHS England via Contracts Finder.

Has "NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1" been awarded?

Yes — 6 awards are recorded, with a reported total value of £10,962,786. The current lifecycle stage is "Award".

Which suppliers are involved in "NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1"?

3 suppliers are linked: Pulse Healthcare Limited, Oviva UK Limited, Momenta Newcastle Ltd.

What is "NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1" worth?

The reported award value is £10,962,786.

When was "NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1" published?

It was first published on 20 Feb 2024 and last updated on 20 Feb 2024, across 2 notices.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable